Administration of 3′-sialyllactose reduced ear, epidermal, and dermal thickness in a mouse model of atopic dermatitis, downregulated the expression of pro-inflammatory and atopic dermatitis-related cytokines, and suppressed mast cell infiltration and IgE levels. Here, IGHE is linked to atopic eczema.